Study drug for advanced solid tumors that can’t be treated
Treatments studied
Part of Cancer clinical trials.
This Phase 1 trial tests HS-20089 in people with advanced solid cancers that have limited standard treatment options. It focuses on safety and early signs of whether the drug can shrink tumors or control them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Have an advanced solid tumor confirmed by biopsy (tissue) or cells, where standard treatment isn’t possible or isn’t tolerated
- Have at least one measurable tumor area on scans (often at least 10 mm, or 15 mm for lymph nodes) and it must be usable for measuring
- Be in reasonably good physical condition (ECOG 0–1) and not have worsened in the last 2 weeks
- Have a life expectancy of more than 12 weeks
- Be able and willing to use effective birth control during the study and for 3 months after, and not breastfeed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 trial tests HS-10386 (an experimental treatment) in people with advanced solid tumors that can’t be cured with standard options. The goal is to find a safe dose and see how the cancer responds.
This phase 1 study tests an investigational drug called HS-20108 in people with advanced solid tumors. It aims to find a safe dose and see how well the drug works against cancer.
This study tests a new combination drug called HS-20093 for people with advanced solid tumors. It aims to see if it is safe and works against cancer that hasn't responded to other treatments.
This trial tests an investigational drug called HS-20093 for people with advanced esophageal cancer or other solid tumors that have not responded to prior treatment. The drug targets a protein on cancer cells called B7-H3, and the study aims to see if it can shrink tumors or slow their growth.
This trial tests a new drug called HS-20105 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug can shrink tumors or slow their growth.
This Phase 1 trial tests a new medicine (HG381) in people with advanced solid tumors to see how safe it is and how it works in the body. It may help if standard treatments have already stopped working or aren’t possible for you.
Hear when a new Advanced Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.